Wilmington Savings Fund Society FSB Lowers Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Wilmington Savings Fund Society FSB cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 36.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,528 shares of the pharmacy operator’s stock after selling 3,717 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Walgreens Boots Alliance were worth $61,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. First Financial Corp IN raised its holdings in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. TD Private Client Wealth LLC raised its stake in Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 3,208 shares in the last quarter. Sentry Investment Management LLC purchased a new stake in Walgreens Boots Alliance during the third quarter worth $30,000. Finally, Eastern Bank bought a new stake in Walgreens Boots Alliance during the 3rd quarter valued at $33,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $9.75 on Friday. The company has a market cap of $8.43 billion, a price-to-earnings ratio of -0.95, a PEG ratio of 1.26 and a beta of 0.65. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock’s fifty day moving average price is $10.26 and its 200 day moving average price is $9.77. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.47.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the company earned $0.66 earnings per share. The company’s revenue was up 7.6% on a year-over-year basis. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently commented on WBA. TD Cowen reduced their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Finally, UBS Group increased their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $13.19.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.